Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-13

Clinical Trial Update: Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion [Phase 4]

View source ↗

Summary

Phase 4 Mayo Clinic trial evaluating glucagon suppression during hyperglycemia with and without amino acid infusion in healthy individuals as well as those with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Healthy, Type 2 Diabetes | Phase 4 | Status: ACTIVE_NOT_RECRUITING